(+)-dexrazoxane multiple interactions ISO RGD:1316728 6480464 [Dexrazoxane co-treated with Idarubicin] results in increased expression of RAD51 mRNA CTD PMID:28973540 (-)-demecolcine affects localization EXP 6480464 Demecolcine affects the localization of RAD51 protein CTD PMID:9885240 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1316727 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RAD51 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:1316728 6480464 vinylidene chloride results in increased expression of RAD51 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1316728 6480464 ethylene dichloride results in decreased expression of RAD51 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RAD51 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1316727 6480464 Estradiol results in increased expression of RAD51 mRNA CTD PMID:16474171 , PMID:18310284 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1316728 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:20566336 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1316728 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316727 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAD51 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RAD51 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316728 6480464 Tetrachlorodibenzodioxin affects the expression of RAD51 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316728 6480464 Tetrachlorodibenzodioxin results in increased expression of RAD51 mRNA CTD PMID:15667827 2,4-diaminotoluene increases expression ISO RGD:1316728 6480464 2, 4-diaminotoluene results in increased expression of RAD51 mRNA CTD PMID:20713471 3-methylcholanthrene increases expression ISO RGD:1316728 6480464 Methylcholanthrene results in increased expression of RAD51 mRNA CTD PMID:20713471 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid decreases activity ISO RGD:1316727 6480464 4 more ... CTD PMID:23589568 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:1316727 6480464 [4 more ... CTD PMID:23589568 4-hydroperoxycyclophosphamide decreases expression EXP 6480464 perfosfamide results in decreased expression of RAD51 mRNA CTD PMID:11754170 4-hydroxynon-2-enal decreases expression ISO RGD:1316728 6480464 4-hydroxy-2-nonenal results in decreased expression of RAD51 mRNA CTD PMID:19191707 4-hydroxynon-2-enal increases expression ISO RGD:1316728 6480464 4-hydroxy-2-nonenal results in increased expression of RAD51 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1316728 6480464 Fenretinide results in increased expression of RAD51 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects localization ISO RGD:1316727 6480464 Decitabine affects the localization of RAD51 protein modified form CTD PMID:17991895 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of RAD51 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:23969067 7,12-dimethyltetraphene multiple interactions ISO RGD:1316728 6480464 A gene mutant form affects the reaction [9 more ... CTD PMID:25448685 7,12-dimethyltetraphene increases expression ISO RGD:1316728 6480464 9 more ... CTD PMID:25448685 , PMID:32553695 7,9-dihydro-1H-purine-2,6,8(3H)-trione decreases expression ISO RGD:1316728 6480464 Uric Acid results in decreased expression of RAD51 mRNA CTD PMID:23619996 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:1316728 6480464 NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of RAD51 mRNA] CTD PMID:23619996 acetamide increases expression EXP 6480464 acetamide results in increased expression of RAD51 mRNA CTD PMID:31881176 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:1316727 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [[Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA], acetylleucyl-leucyl-norleucinal inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of RAD51 protein]] CTD PMID:21810436 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of RAD51 mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO RGD:1316727 6480464 tetrachlorobenzoquinone promotes the reaction [Dactinomycin results in decreased expression of RAD51 mRNA] CTD PMID:27989139 actinomycin D decreases expression ISO RGD:1316727 6480464 Dactinomycin results in decreased expression of RAD51 mRNA CTD PMID:27989139 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of RAD51 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 increases expression ISO RGD:1316727 6480464 Aflatoxin B1 results in increased expression of RAD51 mRNA CTD PMID:29445054 all-trans-retinoic acid affects expression ISO RGD:1316727 6480464 Tretinoin affects the expression of RAD51 mRNA CTD PMID:31600526 amsacrine affects response to substance ISO RGD:1316727 6480464 RAD51 protein affects the susceptibility to Amsacrine CTD PMID:16600179 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1316727 6480464 pyrazolanthrone inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] CTD PMID:22579953 arsane affects methylation ISO RGD:1316727 6480464 Arsenic affects the methylation of RAD51 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1316727 6480464 Arsenic affects the methylation of RAD51 gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:1316728 6480464 arsenite results in decreased expression of RAD51 mRNA CTD PMID:18929588 benzene decreases expression ISO RGD:1316727 6480464 Benzene results in decreased expression of RAD51 mRNA CTD PMID:18724895 benzene multiple interactions ISO RGD:1316728 6480464 TRP53 protein affects the reaction [Benzene results in decreased expression of RAD51 mRNA] CTD PMID:12928149 benzene increases expression ISO RGD:1316728 6480464 Benzene results in increased expression of RAD51 mRNA CTD PMID:15342939 benzo[a]pyrene decreases expression ISO RGD:1316727 6480464 Benzo(a)pyrene results in decreased expression of RAD51 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1316727 6480464 Benzo(a)pyrene results in increased expression of RAD51 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1316727 6480464 Benzo(a)pyrene affects the methylation of RAD51 intron CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1316728 6480464 Benzo(a)pyrene results in increased expression of RAD51 mRNA CTD PMID:20713471 , PMID:32417428 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1316727 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1316728 6480464 benzo(b)fluoranthene results in increased expression of RAD51 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 benzo[e]pyrene decreases methylation ISO RGD:1316727 6480464 benzo(e)pyrene results in decreased methylation of RAD51 intron CTD PMID:30157460 biphenyl-4-amine decreases expression ISO RGD:1316727 6480464 4-biphenylamine results in decreased expression of RAD51 mRNA CTD PMID:24857880 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1316727 6480464 BRCA2 protein inhibits the reaction [Mustard Gas affects the localization of RAD51 protein] CTD PMID:20435105 bis(2-chloroethyl) sulfide decreases response to substance ISO RGD:1316727 6480464 RAD51 protein results in decreased susceptibility to Mustard Gas CTD PMID:20435105 bis(2-chloroethyl) sulfide affects localization ISO RGD:1316727 6480464 Mustard Gas affects the localization of RAD51 protein CTD PMID:20435105 bisphenol A increases expression ISO RGD:1316727 6480464 bisphenol A results in increased expression of RAD51 mRNA CTD PMID:16474171 , PMID:22576693 bisphenol A decreases expression ISO RGD:1316727 6480464 bisphenol A results in decreased expression of RAD51 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RAD51 mRNA CTD PMID:25181051 bortezomib decreases expression ISO RGD:1316727 6480464 Bortezomib results in decreased expression of RAD51 mRNA CTD PMID:21917757 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of RAD51 mRNA CTD PMID:32479839 busulfan decreases expression ISO RGD:1316728 6480464 Busulfan results in decreased expression of RAD51 mRNA CTD PMID:15388331 cadmium dichloride increases expression ISO RGD:1316727 6480464 Cadmium Chloride results in increased expression of RAD51 mRNA CTD PMID:12160620 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of RAD51 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1316727 6480464 Calcitriol results in decreased expression of RAD51 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1316727 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51 mRNA CTD PMID:21592394 camptothecin decreases expression ISO RGD:1316727 6480464 Camptothecin results in decreased expression of RAD51 mRNA, Camptothecin results in decreased expression of RAD51 protein CTD PMID:10344722 , PMID:24792648 carbamazepine affects expression ISO RGD:1316727 6480464 Carbamazepine affects the expression of RAD51 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:1316728 6480464 Nanotubes, Carbon analog results in increased expression of RAD51 mRNA, Nanotubes, Carbon results in increased expression of RAD51 mRNA CTD PMID:25554681 carmustine decreases expression ISO RGD:1316727 6480464 Carmustine results in decreased expression of RAD51 mRNA CTD PMID:15980968 chlorambucil increases expression ISO RGD:1316727 6480464 Chlorambucil results in increased expression of RAD51 protein CTD PMID:10473103 chlorothalonil increases expression ISO RGD:1316728 6480464 tetrachloroisophthalonitrile results in increased expression of RAD51 protein CTD PMID:30586609 choline multiple interactions ISO RGD:1316728 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAD51 more ... CTD PMID:20938992 chromium(6+) multiple interactions ISO RGD:1316727 6480464 chromium hexavalent ion affects the phosphorylation of and affects the expression of RAD51 protein, chromium hexavalent ion results in decreased expression of and results in decreased localization of RAD51 protein CTD PMID:25173789 , PMID:27449664 chromium(6+) decreases expression ISO RGD:1316727 6480464 chromium hexavalent ion results in decreased expression of RAD51 mRNA CTD PMID:30690063 chrysene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of RAD51 mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1316728 6480464 Cisplatin results in increased expression of RAD51 protein CTD PMID:26723870 cisplatin multiple interactions ISO RGD:1316728 6480464 NQO1 protein affects the reaction [Cisplatin results in increased expression of RAD51 protein] CTD PMID:26723870 cisplatin increases expression ISO RGD:1316727 6480464 Cisplatin results in increased expression of RAD51 mRNA, Cisplatin results in increased expression of RAD51 protein CTD PMID:26723870 , PMID:27594783 copper atom multiple interactions ISO RGD:1316727 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RAD51 mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:1316728 6480464 Copper results in increased expression of RAD51 mRNA CTD PMID:17205981 copper(0) multiple interactions ISO RGD:1316727 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RAD51 mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:1316728 6480464 Copper results in increased expression of RAD51 mRNA CTD PMID:17205981 copper(II) sulfate decreases expression ISO RGD:1316727 6480464 Copper Sulfate results in decreased expression of RAD51 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1316727 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1316727 6480464 Coumestrol results in increased expression of RAD51 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1316728 6480464 Asbestos, Crocidolite results in increased expression of RAD51 mRNA CTD PMID:29279043 crocidolite asbestos decreases expression ISO RGD:1316727 6480464 Asbestos, Crocidolite results in decreased expression of RAD51 mRNA CTD PMID:29523930 CU-O LINKAGE increases expression ISO RGD:1316727 6480464 cupric oxide results in increased expression of RAD51 mRNA CTD PMID:32285662 curcumin multiple interactions ISO RGD:1316727 6480464 [Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA more ... CTD PMID:21810436 cyclophosphamide decreases expression ISO RGD:1316728 6480464 Cyclophosphamide results in decreased expression of RAD51 mRNA CTD PMID:21041162 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of RAD51 mRNA CTD PMID:11599041 cyclosporin A decreases expression ISO RGD:1316727 6480464 Cyclosporine results in decreased expression of RAD51 mRNA CTD PMID:25562108 cylindrospermopsin decreases expression ISO RGD:1316727 6480464 cylindrospermopsin results in decreased expression of RAD51 mRNA CTD PMID:23726867 cypermethrin increases expression ISO RGD:1316728 6480464 cypermethrin results in increased expression of RAD51 mRNA CTD PMID:21142847 cytarabine increases expression ISO RGD:1316727 6480464 Cytarabine results in increased expression of RAD51 mRNA CTD PMID:19194470 dexamethasone decreases expression ISO RGD:1316728 6480464 Dexamethasone results in decreased expression of RAD51 mRNA CTD PMID:21041162 dibenz[a,h]anthracene increases expression ISO RGD:1316728 6480464 1 more ... CTD PMID:26377693 dibenzofuran decreases expression EXP 6480464 dibenzofuran analog results in decreased expression of RAD51 mRNA CTD PMID:20566336 dichloroacetic acid increases expression ISO RGD:1316728 6480464 Dichloroacetic Acid results in increased expression of RAD51 mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:1316727 6480464 Diclofenac affects the expression of RAD51 mRNA CTD PMID:24752500 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of RAD51 mRNA CTD PMID:30723492 diethylstilbestrol decreases expression ISO RGD:1316728 6480464 Diethylstilbestrol results in decreased expression of RAD51 mRNA CTD PMID:21041162 dioxygen decreases expression ISO RGD:1316727 6480464 Oxygen deficiency results in decreased expression of RAD51 mRNA, Oxygen deficiency results in decreased expression of RAD51 protein CTD PMID:25030372 more ... disodium selenite decreases expression ISO RGD:1316727 6480464 Sodium Selenite results in decreased expression of RAD51 mRNA, Sodium Selenite results in decreased expression of RAD51 protein CTD PMID:10344722 , PMID:18175754 doxorubicin affects expression ISO RGD:1316727 6480464 Doxorubicin affects the expression of RAD51 protein CTD PMID:17351394 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of RAD51 mRNA, Doxorubicin results in decreased expression of RAD51 protein CTD PMID:24902966 , PMID:27181935 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in decreased expression of RAD51 mRNA], Quercetin inhibits the reaction [Doxorubicin results in decreased expression of RAD51 protein] CTD PMID:24902966 , PMID:27181935 doxorubicin decreases expression ISO RGD:1316727 6480464 Doxorubicin results in decreased expression of RAD51 mRNA, Doxorubicin results in decreased expression of RAD51 protein CTD PMID:10344722 endosulfan multiple interactions ISO RGD:1316727 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAD51 mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of RAD51 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1316727 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA CTD PMID:19167446 erlotinib hydrochloride multiple interactions ISO RGD:1316727 6480464 [Erlotinib Hydrochloride results in decreased activity of EGFR protein] which results in decreased expression of RAD51 protein CTD PMID:23548265 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of RAD51 mRNA CTD PMID:24412560 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of RAD51 mRNA CTD PMID:24412560 Estragole increases expression EXP 6480464 estragole results in increased expression of RAD51 protein CTD PMID:29054680 etoposide affects localization EXP 6480464 Etoposide affects the localization of RAD51 protein CTD PMID:9885240 flumequine multiple interactions ISO RGD:1316728 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 folic acid multiple interactions ISO RGD:1316728 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAD51 more ... CTD PMID:20938992 folic acid decreases expression ISO RGD:1316728 6480464 Folic Acid results in decreased expression of RAD51 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1316727 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of RAD51 mRNA CTD PMID:19016759 fulvestrant decreases expression ISO RGD:1316727 6480464 fulvestrant results in decreased expression of RAD51 mRNA CTD PMID:19016759 furan decreases expression EXP 6480464 furan results in decreased expression of RAD51 mRNA CTD PMID:22507866 furan increases expression EXP 6480464 furan results in increased expression of RAD51 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1316727 6480464 Genistein results in increased expression of RAD51 mRNA CTD PMID:16474171 geraniol decreases expression ISO RGD:1316727 6480464 geraniol results in decreased expression of RAD51 mRNA CTD PMID:27683099 idarubicin multiple interactions ISO RGD:1316728 6480464 [Dexrazoxane co-treated with Idarubicin] results in increased expression of RAD51 mRNA CTD PMID:28973540 irinotecan multiple interactions ISO RGD:1316727 6480464 [Irinotecan co-treated with 2-(morpholin-4-yl)benzo(h)chromen-4-one] results in increased expression of RAD51 protein, [Irinotecan co-treated with IC486241] results in increased expression of RAD51 protein CTD PMID:21221710 irinotecan increases expression ISO RGD:1316727 6480464 Irinotecan results in increased expression of RAD51 protein CTD PMID:21221710 L-methionine multiple interactions ISO RGD:1316728 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAD51 more ... CTD PMID:20938992 leflunomide decreases expression ISO RGD:1316727 6480464 leflunomide results in decreased expression of RAD51 mRNA CTD PMID:28988120 , PMID:29427785 lipopolysaccharide increases expression ISO RGD:1316728 6480464 Lipopolysaccharides results in increased expression of RAD51 mRNA CTD PMID:12057914 lucanthone decreases expression ISO RGD:1316727 6480464 Lucanthone results in decreased expression of RAD51 mRNA CTD PMID:21148553 mechlorethamine increases expression ISO RGD:1316728 6480464 Mechlorethamine results in increased expression of RAD51 protein CTD PMID:25891025 MeIQx multiple interactions ISO RGD:1316728 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 menadione affects expression ISO RGD:1316727 6480464 Vitamin K 3 affects the expression of RAD51 mRNA CTD PMID:20044591 methapyrilene decreases methylation ISO RGD:1316727 6480464 Methapyrilene results in decreased methylation of RAD51 intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1316727 6480464 Methyl Methanesulfonate results in increased expression of RAD51 mRNA CTD PMID:23649840 mitomycin C multiple interactions ISO RGD:1316727 6480464 [Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA more ... CTD PMID:21810436 mitomycin C increases expression ISO RGD:1316727 6480464 Mitomycin results in increased expression of RAD51 protein CTD PMID:21810436 myristicin decreases expression ISO RGD:1316727 6480464 myristicin results in decreased expression of RAD51 mRNA CTD PMID:24792648 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1316727 6480464 N more ... CTD PMID:12888634 N,N-dimethylformamide increases expression ISO RGD:1316727 6480464 Dimethylformamide results in increased expression of RAD51 mRNA, Dimethylformamide results in increased expression of RAD51 protein CTD PMID:26387567 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1316727 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of RAD51 protein]] CTD PMID:21810436 N-nitrosodiethylamine multiple interactions ISO RGD:1316728 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RAD51 mRNA, RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RAD51 mRNA] CTD PMID:17854601 , PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:1316728 6480464 Diethylnitrosamine results in increased expression of RAD51 mRNA, Diethylnitrosamine results in increased expression of RAD51 protein CTD PMID:17854601 , PMID:18506893 nickel atom increases expression ISO RGD:1316727 6480464 Nickel results in increased expression of RAD51 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of RAD51 mRNA CTD PMID:22110744 nickel dichloride decreases expression ISO RGD:1316727 6480464 nickel chloride results in decreased expression of RAD51 mRNA, nickel chloride results in decreased expression of RAD51 protein CTD PMID:28472268 Nonidet P-40 decreases expression ISO RGD:1316727 6480464 Nonidet P-40 results in decreased expression of RAD51 mRNA CTD PMID:26552463 ochratoxin A multiple interactions ISO RGD:1316727 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of RAD51] more ... CTD PMID:24525463 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of RAD51 mRNA, ochratoxin A results in increased expression of RAD51 protein CTD PMID:24243707 ochratoxin A decreases expression ISO RGD:1316727 6480464 ochratoxin A results in decreased expression of RAD51 CTD PMID:24525463 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RAD51 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of RAD51 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1316728 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of RAD51 mRNA, TTPA protein affects the reaction [Ozone results in increased expression of RAD51 mRNA] CTD PMID:19555225 , PMID:25658374 paracetamol increases expression ISO RGD:1316727 6480464 Acetaminophen results in increased expression of RAD51 mRNA CTD PMID:22230336 phenethyl isothiocyanate decreases expression ISO RGD:1316727 6480464 phenethyl isothiocyanate results in decreased expression of RAD51 mRNA CTD PMID:26678675 phenobarbital multiple interactions ISO RGD:1316728 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RAD51 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RAD51 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1316728 6480464 Phenobarbital results in increased expression of RAD51 mRNA CTD PMID:19482888 , PMID:23091169 phosphoramide mustard affects expression EXP 6480464 phosphoramide mustard affects the expression of RAD51 mRNA, phosphoramide mustard affects the expression of RAD51 protein CTD PMID:25497287 phosphoramide mustard decreases expression EXP 6480464 phosphoramide mustard results in decreased expression of RAD51 protein CTD PMID:26708502 phosphoramide mustard increases expression EXP 6480464 phosphoramide mustard results in increased expression of RAD51 mRNA CTD PMID:26708502 phytoestrogen increases expression ISO RGD:1316727 6480464 Phytoestrogens results in increased expression of RAD51 mRNA CTD PMID:18310284 pirinixic acid multiple interactions ISO RGD:1316728 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of RAD51 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of RAD51 mRNA] CTD PMID:17950772 , PMID:20813756 pirinixic acid increases expression ISO RGD:1316728 6480464 pirinixic acid results in increased expression of RAD51 mRNA CTD PMID:17950772 more ... potassium chromate multiple interactions ISO RGD:1316727 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RAD51 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1316727 6480464 potassium chromate(VI) results in decreased expression of RAD51 mRNA CTD PMID:22079256 , PMID:22714537 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1316728 6480464 [1 more ... CTD PMID:23626729 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1316728 6480464 Pregnenolone Carbonitrile results in increased expression of RAD51 mRNA CTD PMID:22698814 prodigiosin multiple interactions ISO RGD:1316727 6480464 pyrazolanthrone inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA], SB 203580 inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] CTD PMID:22579953 prodigiosin decreases response to substance ISO RGD:1316727 6480464 RAD51 protein results in decreased susceptibility to Prodigiosin CTD PMID:22579953 prodigiosin decreases expression ISO RGD:1316727 6480464 Prodigiosin results in decreased expression of RAD51 mRNA, Prodigiosin results in decreased expression of RAD51 protein CTD PMID:22579953 progesterone affects expression ISO RGD:1316728 6480464 Progesterone affects the expression of RAD51 mRNA CTD PMID:17251523 propiconazole increases expression ISO RGD:1316728 6480464 propiconazole results in increased expression of RAD51 mRNA CTD PMID:21278054 quercetin increases expression EXP 6480464 Quercetin results in increased expression of RAD51 protein CTD PMID:24902966 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of RAD51 protein] CTD PMID:24902966 resveratrol increases expression ISO RGD:1316727 6480464 resveratrol results in increased expression of RAD51 mRNA CTD PMID:15149879 resveratrol multiple interactions ISO RGD:1316727 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of RAD51 mRNA CTD PMID:19167446 rotenone increases expression ISO RGD:1316727 6480464 Rotenone results in increased expression of RAD51 mRNA CTD PMID:18191903 SB 203580 multiple interactions ISO RGD:1316727 6480464 SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of RAD51], SB 203580 inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] CTD PMID:22579953 , PMID:24525463 silicon dioxide increases expression ISO RGD:1316728 6480464 Silicon Dioxide results in increased expression of RAD51 mRNA CTD PMID:29341224 sirolimus multiple interactions ISO RGD:1316727 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of RAD51 mRNA CTD PMID:19016759 sodium arsenite decreases expression ISO RGD:1316728 6480464 sodium arsenite results in decreased expression of RAD51 mRNA CTD PMID:16014739 , PMID:25787150 sodium arsenite increases expression ISO RGD:1316727 6480464 sodium arsenite results in increased expression of RAD51 mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of RAD51 mRNA CTD PMID:22110744 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RAD51 mRNA CTD PMID:25993096 sodium dichromate increases expression ISO RGD:1316728 6480464 sodium bichromate results in increased expression of RAD51 mRNA CTD PMID:22155349 sunitinib decreases expression ISO RGD:1316727 6480464 Sunitinib results in decreased expression of RAD51 mRNA CTD PMID:31533062 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of RAD51 protein CTD PMID:17219426 testosterone multiple interactions ISO RGD:1316727 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1316727 6480464 Testosterone results in decreased expression of RAD51 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1316728 6480464 Carbon Tetrachloride results in increased expression of RAD51 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane affects expression ISO RGD:1316728 6480464 Carbon Tetrachloride affects the expression of RAD51 mRNA CTD PMID:17484886 tetraphene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RAD51 mRNA CTD PMID:22659510 titanium dioxide increases expression ISO RGD:1316728 6480464 titanium dioxide results in increased expression of RAD51 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of RAD51 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RAD51 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1316728 6480464 Trichloroethylene results in increased expression of RAD51 mRNA CTD PMID:25549359 trichostatin A decreases expression ISO RGD:1316727 6480464 trichostatin A results in decreased expression of RAD51 mRNA CTD PMID:23770000 trimellitic anhydride increases expression ISO RGD:1316728 6480464 trimellitic anhydride results in increased expression of RAD51 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1316727 6480464 troglitazone results in decreased expression of RAD51 mRNA CTD PMID:19140230 urethane decreases expression ISO RGD:1316727 6480464 Urethane results in decreased expression of RAD51 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1316727 6480464 Valproic Acid results in decreased expression of RAD51 mRNA CTD PMID:20585447 valproic acid decreases expression ISO RGD:1316728 6480464 Valproic Acid results in decreased expression of RAD51 mRNA CTD PMID:24913804 valproic acid increases expression ISO RGD:1316728 6480464 Valproic Acid results in increased expression of RAD51 mRNA CTD PMID:24913804 vorinostat decreases expression ISO RGD:1316727 6480464 vorinostat results in decreased expression of RAD51 protein CTD PMID:20646843 zearalenone increases expression ISO RGD:1316728 6480464 Zearalenone results in increased expression of RAD51 mRNA, Zearalenone results in increased expression of RAD51 protein CTD PMID:28552778 zearalenone decreases expression ISO RGD:1316728 6480464 Zearalenone results in decreased expression of RAD51 mRNA CTD PMID:27862621 zinc oxide multiple interactions ISO RGD:1316728 6480464 Zinc Oxide affects the splicing of and results in increased expression of RAD51 mRNA CTD PMID:30500950
Gene-Chemical Interaction Annotations
